首页> 外文期刊>Iranian red crescent medical journal >Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
【24h】

Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer

机译:C-MYC基因扩增表达与胃癌临床病理特征的关系

获取原文
           

摘要

The incidence rate of gastric cancer in western countries has shown a remarkable decline in the recent years while it is still the most common cancer among males in Iran. The proto-oncogene MYC, located at 8q24.1, regulates almost 15% of human genes and is activated in 20% of all tumors. The amplification of MYC and overexpression of its protein product are observed in 15 - 30% of gastric neoplasias. Objectives: The objective of this study was to find the preferences of Chromogenic In Situ Hybridization (CISH) and Immunohistochemistry (IHC) in diagnosis and prognosis of gastric cancer. Patients and Methods: We studied 102 samples of gastric cancer in Iran and all the patients had undergone primary surgical resection at the Cancer Institute Hospital, Tehran University of Medical Sciences. The CISH and IHC techniques were applied for all our samples. All of the samples had adenocarcinoma gastric cancer and were selected randomly. Also, the type of study was cross sectional. The sample size was 100 patients. Results: Our data revealed that both diffuse and intestinal types of gastric cancer occurred significantly more in males than females. Our results showed that there was an indication of some correlation between grades and CISH, although the difference was not significant. Our data also showed that CISH positive patients (43%) were more frequent compared to IHC positive patients (14.7%). There was a correlation between CISH and IHC. These results revealed that there was a significant difference between grades and IHC. There was also no statistical difference between CISH amplification in diffuse and intestinal types. Conclusions: From the results, it could be concluded that for administration of the treatment of stomach cancer, and progress and prognosis of tumor, which is important for patients and clinicians, the CISH is a better and more feasible test than IHC, in regards to sensitivity and specificity.
机译:近年来,西方国家胃癌的发病率显着下降,尽管它仍然是伊朗男性中最常见的癌症。位于8q24.1的原癌基因MYC调节近15%的人类基因,并在20%的所有肿瘤中被激活。在15-30%的胃肿瘤中观察到MYC的扩增及其蛋白产物的过表达。目的:本研究的目的是寻找发色原位杂交(CISH)和免疫组织化学(IHC)在胃癌的诊断和预后中的偏爱。患者和方法:我们在伊朗研究了102份胃癌样本,所有患者均在德黑兰医科大学癌症研究所医院进行了一次外科手术切除。 CISH和IHC技术适用于我们所有的样品。所有样品均患有腺癌胃癌,并随机选择。同样,研究类型为横断面。样本量为100名患者。结果:我们的数据显示,男性的弥漫性和肠道类型均明显高于女性。我们的结果表明,成绩与CISH之间存在一定的相关性,尽管差异并不显着。我们的数据还显示,与IHC阳性患者(14.7%)相比,CISH阳性患者(43%)的发病率更高。 CISH与IHC之间存在相关性。这些结果表明,年级和IHC之间存在显着差异。在弥散型和肠道型中,CISH扩增之间也没有统计学差异。结论:从结果可以得出结论,对于胃癌的治疗以及肿瘤的进展和预后,这对于患者和临床医生而言都很重要,就IHC而言,CISH测试比IHC更好,更可行。敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号